Post-Docs
Dr. Sofia Bartlett is a postdoctoral research fellow in the clinical prevention services division at the British Columbia Centre for Disease Control and Department of Pathology and Laboratory Medicine at the University of British Columbia. She obtained her Doctorate degree (PhD) in Molecular Epidemiology at the Kirby Institute, University of New South Wales in Sydney, Australia. Her research focusses on improving the health of marginalised populations, such as people who inject drugs and people living with hepatitis C infection. Sofia’s research utilizes a multidisciplinary approach, combining molecular genetics, bioinformatics and clinical epidemiology, and she is currently working on applying syndemic theory to understand factors related to gaps in the care cascade for hepatitis C infection in British Columbia.
Email: [email protected]
Dr. Maryam Darvishian is a postdoctoral research fellow in the clinical prevention services division at the BC Centre for Disease Control (BCCDC) and School of Population and Public Health, University of British Columbia. She obtained her Master of Science degree (MSc) in Clinical and Psychosocial Epidemiology and Doctorate degree (PhD) in Epidemiology/Pharmaco-Epidemiology at University Medical Center Groningen (UMCG), Netherlands. At BCCDC her research focuses on hepatitis C treatments effectiveness and disease outcomes. Her research interest includes epidemiology and pharmaco-epidemiology of infectious diseases, real-world treatment effectiveness and bias-adjustment techniques in observational study designs.
Email: [email protected]
Dr. Margo Pearce is a CIHR Health Systems Impact Fellowship-supported postdoctoral fellow in the clinical prevention division at BC Centre for Disease Control and UBC School of Population and Public Health (SPPH). She completed her MPP at Simon Fraser University, her MSc at the London School of Hygiene and Tropical Medicine, and her PhD at UBC SPPH. In addition, she completed a postdoctoral fellowship with the Canadian HIV Trials Network. Margo's research interests include Indigenous people's health and wellness; adversity, resilience, and health over the life course; and healing-centred health policies and systems. Her current postdoctoral research at BCCDC is in partnership with the First Nations Health Authority. This work seeks to: 1) identify systemic deficiencies in the provision of HCV care to First Nations in BC, and 2) apply a strengths and wellness-based perspective to First Nations people’s experiences within the HCV cascade of care.
Dr. Prince A. Adu is a postdoctoral research fellow in the clinical prevention services division at the BC Centre for Disease Control (BCCDC). He obtained a master of public health and a master’s in international development studies both from Ohio University. He completed his PhD at UBC’s School of Population and Public Health. Prince’s research interest involves the application of statistical modeling approaches to understand the structural drivers of epidemics. His current research focusses on the benefits of multi-component interventions (direct-acting antiviral treatments, opioid agonist therapy, psychotherapy etc.) to reduce hepatitis C associated deaths.
E-mail: [email protected]
Dr. Carmine Rossi is a CanHepC-supported postdoctoral research fellow in the viral hepatitis division at the British Columbia Centre for Disease Control. He completed his MSc and PhD in Epidemiology at McGill University in Montreal, Canada. His research interests include HCV treatment uptake in the area of direct-acting antivirals, risk factors for HCV re-infection after successful treatment, extrahepatic manifestations associated with chronic infection, and health-care service utilization among key populations, including injection drug users, immigrants and aboriginals. His methodologic interests include the analysis of complex longitudinal data, the use of time-to-event models, and the incorporation of administrative data-linkages to answer public health questions.
Email: [email protected]